FDA — authorised 22 November 1997
- Application: NDA020632
- Marketing authorisation holder: ABBOTT
- Local brand name: MERIDIA
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 sibutramine hydochloride monohydrate in United States
FDA authorised sibutramine hydochloride monohydrate on 22 November 1997
Marketing authorisation
Other Obesity / Weight Management approved in United States
Frequently asked questions
Is sibutramine hydochloride monohydrate approved in United States?
Yes. FDA authorised it on 22 November 1997.
Who is the marketing authorisation holder for sibutramine hydochloride monohydrate in United States?
ABBOTT holds the US marketing authorisation.